Animal-Assisted Therapy Improves Communication and Mobility among Institutionalized People with Cognitive Impairment.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
14 08 2020
Historique:
received: 14 07 2020
revised: 02 08 2020
accepted: 12 08 2020
entrez: 23 8 2020
pubmed: 23 8 2020
medline: 1 12 2020
Statut: epublish

Résumé

Disorders of communication, social relationships, and psychomotricity are often characterized by cognitive impairment, which hinders daily activities and increases the risk of falls. This study aimed to evaluate the efficacy of an animal-assisted therapy (AAT) program in an institutionalized geriatric population with cognitive impairment. The variables evaluated included level of communication and changes in gait and/or balance. We performed a two-arm, parallel controlled, open-label, nonrandomized cluster clinical trial in two nursing home centers from an urban area. Patients in the two centers received 12 weekly sessions of physiotherapy, but the experimental group included AAT with a therapy dog. The study included a total of 46 patients (23 Control Group [CG], 23 Experimental Group [EG]) with a median age of 85.0 years. Of these, 32.6% had mild-moderate cognitive decline (Global Deterioration Scale of Reisberg [GDS] 2-4) and 67.4% severe cognitive decline (GDS 5-6). After the intervention, patients in the CG and EG showed a statistically significant improvement in all the response variables. When comparing both groups, no statistically significant differences were found in any of the Tinetti scale results (measuring gait and balance). However, the communication of patients in the EG, measured on the Holden scale, showed a statistically significant greater improvement postintervention than that of patients in the CG. AAT can be useful as a complementary, effective treatment for patients with different degrees of cognitive decline.

Identifiants

pubmed: 32823839
pii: ijerph17165899
doi: 10.3390/ijerph17165899
pmc: PMC7459682
pii:
doi:

Types de publication

Controlled Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Psychogeriatrics. 2019 May;19(3):219-227
pubmed: 30393989
Am J Alzheimers Dis Other Demen. 2015 May;30(3):276-89
pubmed: 25118333
Clin Nurs Res. 2014 Feb;23(1):7-19
pubmed: 23800890
Psychogeriatrics. 2016 Jul;16(4):240-6
pubmed: 26370064
Int J Nurs Stud. 2017 Jan;66:37-46
pubmed: 27951433
J Rehabil Res Dev. 2006 May-Jun;43(3):357-66
pubmed: 17041821
Am Fam Physician. 2000 Apr 1;61(7):2159-68, 2173-4
pubmed: 10779256
BMC Psychiatry. 2019 Sep 6;19(1):276
pubmed: 31492131
Clin Interv Aging. 2016 Aug 09;11:1043-9
pubmed: 27570449
Int J Environ Res Public Health. 2019 Aug 09;16(16):
pubmed: 31395808
Int Psychogeriatr. 2011 Aug;23(6):899-905
pubmed: 21356158
Clin Nurs Res. 2019 Jan;28(1):9-29
pubmed: 29441797
Int Psychogeriatr. 2006 Dec;18(4):597-611
pubmed: 16640796
J Clin Psychol. 1992 Sep;48(5):627-33
pubmed: 1401147
Stroke. 2017 Jul;48(7):1916-1924
pubmed: 28619985
J Clin Nurs. 2011 Apr;20(7-8):969-78
pubmed: 21309873
Nurs Older People. 2014 Apr;26(3):31-8
pubmed: 24673326
J Psychiatr Res. 2013 Jun;47(6):762-73
pubmed: 23369337
J Commun Disord. 2007 May-Jun;40(3):215-24
pubmed: 16950329
BMC Complement Altern Med. 2017 Jul 10;17(1):358
pubmed: 28693538
Soins Gerontol. 2012 Mar-Apr;(94):11-4
pubmed: 22611886
Neuropsychology. 2018 Jan;32(1):54-64
pubmed: 29035068
J Geriatr Psychiatry Neurol. 2020 Mar;33(2):109-119
pubmed: 31422765
Curr Gerontol Geriatr Res. 2014;2014:623203
pubmed: 25477957
Complement Ther Med. 2014 Apr;22(2):371-90
pubmed: 24731910
Scand J Occup Ther. 2019 Oct;26(6):433-440
pubmed: 29693512
Sci Rep. 2019 Apr 9;9(1):5831
pubmed: 30967589
PLoS One. 2015 Apr 29;10(4):e0122085
pubmed: 25924013
Int J Environ Res Public Health. 2019 Sep 06;16(18):
pubmed: 31489875
Alzheimers Res Ther. 2015 Mar 26;7(1):34
pubmed: 25815064
Geriatr Nurs. 2016 Jul-Aug;37(4):284-91
pubmed: 27155968
Soins Gerontol. 2013 Jan-Feb;(99):10-2
pubmed: 23409670
JAMA. 1988 Feb 26;259(8):1190-3
pubmed: 3339820
Dement Geriatr Cogn Disord. 2010;30(2):161-78
pubmed: 20838046
BMJ Open. 2016 Dec 13;6(12):e013447
pubmed: 27965255
Front Hum Neurosci. 2017 May 16;11:262
pubmed: 28559806
Am J Alzheimers Dis Other Demen. 2010 Feb;25(1):37-45
pubmed: 19075298
Clin Nurs Res. 2019 Aug 6;:1054773819867250
pubmed: 31387390
Arch Neurol. 1996 Jun;53(6):498-502
pubmed: 8660150
Coll Antropol. 2013 Sep;37(3):973-6
pubmed: 24308245
Psychiatry Res. 2018 Feb;260:418-427
pubmed: 29268204
Int J Older People Nurs. 2015 Jun;10(2):84-93
pubmed: 24814254
Am J Geriatr Psychiatry. 2013 Nov;21(11):1052-9
pubmed: 23831177
Int J Qual Stud Health Well-being. 2017 Dec;12(1):1347013
pubmed: 28699394
Z Gerontol Geriatr. 2013 Apr;46(3):233-6
pubmed: 23474867
Am J Psychiatry. 1982 Sep;139(9):1136-9
pubmed: 7114305
NeuroRehabilitation. 2010;27(2):155-63
pubmed: 20871145
South Med J. 2014 Apr;107(4):265-73
pubmed: 24937523
Am J Alzheimers Dis Other Demen. 2017 Feb;32(1):41-50
pubmed: 27899433
Ann Rehabil Med. 2012 Dec;36(6):756-61
pubmed: 23342306
Am J Occup Ther. 2017 Sep/Oct;71(5):7105190030p1-7105190030p10
pubmed: 28809656
J Phys Ther Sci. 2014 Feb;26(2):309-11
pubmed: 24648655

Auteurs

Maylos Rodrigo-Claverol (M)

Primary Health Care Center Bordeta-Magraners, Catalan Institute of Health, 25001 Lleida, Spain.
Ilerkan Association, 25005 Lleida, Spain.

Belén Malla-Clua (B)

Primary Health Care Center Bordeta-Magraners, Catalan Institute of Health, 25001 Lleida, Spain.

Carme Marquilles-Bonet (C)

Primary Health Care Center Bordeta-Magraners, Catalan Institute of Health, 25001 Lleida, Spain.

Joaquim Sol (J)

Research Support Unit Lleida, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
Institut Català de la Salut, Atenció Primària, 25007 Lleida, Spain.
Metabolic Physiopathology Research Group, Experimental Medicine Department, Lleida University-Lleida Biochemical Research Institute (UdL-IRBLleida), 25198 Lleida, Spain.

Júlia Jové-Naval (J)

Primary Health Care Center Bordeta-Magraners, Catalan Institute of Health, 25001 Lleida, Spain.
Ilerkan Association, 25005 Lleida, Spain.

Meritxell Sole-Pujol (M)

Ilerkan Association, 25005 Lleida, Spain.

Marta Ortega-Bravo (M)

Research Support Unit Lleida, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
Institut Català de la Salut, Atenció Primària, 25007 Lleida, Spain.
Research Group in Therapies in Primary Care, Research Support Unit Lleida, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH